Pedro Lichtinger - Net Worth and Insider Trading
Pedro Lichtinger Net Worth
The estimated net worth of Pedro Lichtinger is at least $6,999 dollars as of 2024-04-25. Pedro Lichtinger is the Director of Lineage Cell Therapeutics Inc and owns about 6,250 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $6,969. Pedro Lichtinger is also the Director of NeuroBo Pharmaceuticals Inc and owns about 10 shares of NeuroBo Pharmaceuticals Inc (NRBO) stock worth over $30. Details can be seen in Pedro Lichtinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pedro Lichtinger has not made any transactions after 2017-03-10 and currently still holds the listed stock(s).
Transaction Summary of Pedro Lichtinger
Pedro Lichtinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pedro Lichtinger owns 3 companies in total, including NeuroBo Pharmaceuticals Inc (NRBO) , Asterias Biotherapeutics Inc (AST) , and Lineage Cell Therapeutics Inc (LCTX) .
Click here to see the complete history of Pedro Lichtinger’s form 4 insider trades.
Insider Ownership Summary of Pedro Lichtinger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NRBO | NeuroBo Pharmaceuticals Inc | 2017-03-10 | director |
| AST | Asterias Biotherapeutics Inc | 2016-01-18 | director & President & CEO |
| LCTX | Lineage Cell Therapeutics Inc | 2012-04-11 | director |
Pedro Lichtinger Latest Holdings Summary
Pedro Lichtinger currently owns a total of 2 stocks. Among these stocks, Pedro Lichtinger owns 6,250 shares of Lineage Cell Therapeutics Inc (LCTX) as of April 11, 2012, with a value of $6,969 and a weighting of 99.57%. Pedro Lichtinger also owns 10 shares of NeuroBo Pharmaceuticals Inc (NRBO) as of March 10, 2017, with a value of $30 and a weighting of 0.43%.
Latest Holdings of Pedro Lichtinger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2012-04-11 | 6,250 | 1.12 | 6,969 |
| NRBO | NeuroBo Pharmaceuticals Inc | 2017-03-10 | 10 | 3.03 | 30 |
Holding Weightings of Pedro Lichtinger
Pedro Lichtinger Form 4 Trading Tracker
According to the SEC Form 4 filings, Pedro Lichtinger has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 6,250 shares on April 11, 2012, which cost Pedro Lichtinger around $24,875.
According to the SEC Form 4 filings, Pedro Lichtinger has made a total of 0 transactions in NeuroBo Pharmaceuticals Inc (NRBO) over the past 5 years. The most-recent trade in NeuroBo Pharmaceuticals Inc is the acquisition of 2 shares on March 10, 2017, which cost Pedro Lichtinger around $99,994.
Insider Trading History of Pedro Lichtinger
- 1
Pedro Lichtinger Trading Performance
GuruFocus tracks the stock performance after each of Pedro Lichtinger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pedro Lichtinger is 9.76%. GuruFocus also compares Pedro Lichtinger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pedro Lichtinger within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pedro Lichtinger's insider trading performs compared to the benchmark.
Performance of Pedro Lichtinger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.94 | 9.76 | 4.39 | -12.74 | -45.45 | -36.5 |
| Relative Return to S&P 500(%) | 16.26 | 9.71 | -0.57 | -28.06 | -57.73 | -47.3 |
Pedro Lichtinger Ownership Network
Ownership Network List of Pedro Lichtinger
Ownership Network Relation of Pedro Lichtinger
Pedro Lichtinger Owned Company Details
What does NeuroBo Pharmaceuticals Inc do?
Who are the key executives at NeuroBo Pharmaceuticals Inc?
Pedro Lichtinger is the director of NeuroBo Pharmaceuticals Inc. Other key executives at NeuroBo Pharmaceuticals Inc include Acting Chief Financial Officer Marshall H Woodworth , Interim CEO and President Joseph Hooker , and 10 percent owner Goldman Sachs Group Inc .
NeuroBo Pharmaceuticals Inc (NRBO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeuroBo Pharmaceuticals Inc (NRBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeuroBo Pharmaceuticals Inc (NRBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeuroBo Pharmaceuticals Inc (NRBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuroBo Pharmaceuticals Inc Insider Transactions
Pedro Lichtinger Mailing Address
Above is the net worth, insider trading, and ownership report for Pedro Lichtinger. You might contact Pedro Lichtinger via mailing address: 1301 Harbor Bay Parkway, Alameda Ca 94502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
